Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2025-10-10
Original market date: See footnote 1
2016-07-18
Product name:
POTASSIUM ACETATE INJECTION USP
Description:
4 MMOL/ML POTASSIUM. 50 ML SINGLE-USE VIALS
DIN:
02362597
Product Monograph/Veterinary Labelling:
Date:
2025-10-10
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
JUNO PHARMA CANADA INC.
11177 Hamon
Montreal
Quebec
Canada
H3M 3E4
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
ETHICAL
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05XA17 POTASSIUM ACETATE
Active ingredient group (AIG) number:See footnote5
0107304002
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| POTASSIUM ACETATE | 39.2 % / W/V |